EZH2 and glioblastoma: This axis’ activation was notably detected in CMV-transformed HMECs (CTH), CMV-transformed OECs (CTO cells), and CMV-elicited glioblastoma cells (CEGBCs) exhibiting a significant increase in Myc and EZH2 proteins.